Medindia

X

ABR-Affinity BioReagents to Participate in the American Association for Cancer Research Meeting in San Diego, California, April 12 - 16, 2008

Saturday, April 12, 2008 General News J E 4
Advertisement
DENVER, and GOLDEN, Colo., April 11 ABR-AffinityBioReagents, a leading global antibody manufacturer, announced today itscontinued support for the American Association for Cancer Research (AACR) andwill exhibit at the annual meeting taking place at the San Diego ConventionCenter, April 12 - 16, 2008.

"The AACR meeting is a highlight of the year for ABR as we devote asignificant portion of our corporate resources to supporting biologicalresearch in this critically important area," said Ken Wilczek, President ofABR-Affinity BioReagents. ABR's product portfolio includes over 3,000 qualityguaranteed cancer biology antibodies. "Attendance at this meeting affords usthe opportunity to enhance our understanding of what today's researchers arefocusing on in terms of potential targets and timelines. Each year there arean increasing number of significant developments contributing to extraordinaryadvances in cancer-related disease research. This is just a great forum inwhich to interact on a personal level with a cross section of the top lifescience researchers in the U.S. and around the world. We derive much of ourstrategic direction from this type of input," finished Mr. Wilczek.

ABR-Affinity BioReagents will be launching 7,500 new products at themeeting across a selection of research areas including: Apoptosis; CancerBiology; Heat Shock Protein; Ion Transport/Regulation; Neurobiology; SignalTransduction; Transcription Regulation; and Vision.

ABR will be located at booth #820 at next week's meeting in San Diego.

About ABR-Affinity BioReagents

Founded in 1989 with world headquarters in Golden, Colorado, ABR-AffinityBioReagents is a world leader in the manufacture and distribution ofmonoclonal and polyclonal antibodies, kits, recombinant proteins, siRNA, andcustom antibody production services, known as Antibody on Demand(R).

With more than 35,000 antibodies focused in 43 research areas, ABR offersa unique value proposition in the life science industry-research antibodiesthat are 100% quality guaranteed or your money back-with no questions asked.

Utilizing a distribution network encompassing over 55 nations, ABRproducts are readily available in every research market on the globe. Productsare available directly from ABR in the United States, as well as through anexclusive distribution partnership with Fisher Scientific, a division ofThermo Fisher Scientific.

For additional information about ABR-Affinity BioReagents, contact LeslieMartin with ABR media relations at 1-800-527-4535.

SOURCE ABR-Affinity BioReagents
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Biopure Operations Compliant With U.K. Manufacturi...
S
Peregrine Pharmaceuticals Announces Four Upcoming ...